SCHEMBL7226758

SCHEMBL7226758

NC(CC(=O)O)c1ccc(-c2ccccn2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.44
DHODH Q02127 2/20 0.44
DPP4 P27487 2/20 0.43
KMT2A Q03164 2/20 0.43
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
DPP7 Q9UHL4 1/20 0.42
TPH1 P17752 1/20 0.42
PARP1 P09874 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
CHEK2 O96017 1/20 0.41
MEN1 O00255 1/20 0.41
OPRD1 P41143 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20546345 0.85 KMT2A (0.52) FFAR1KMT2ASMN1; SMN2
SCHEMBL20546348 0.85 KMT2A (0.52) FFAR1KMT2ASMN1; SMN2
SCHEMBL13802832 0.83 KDM4E (0.43) DPP4S1PR3CYP1A2CYP2D6CYP19A1
SCHEMBL1310193 0.81 FFAR1 (0.56) FFAR1KMT2ASMN1; SMN2TPH1
SCHEMBL20545703 0.81 FFAR1 (0.56) FFAR1KMT2ASMN1; SMN2TPH1
Hydrochloric Acid SCHEMBL6949714 0.79 FFAR1 (0.54) FFAR1KMT2ASMN1; SMN2TPH1
SCHEMBL288753 0.77 GABBR2 (0.59) DPP4KMT2ASMN1; SMN2CYP2D6CYP2C19
SCHEMBL123765 0.77 GABBR2 (0.59) DPP4KMT2ASMN1; SMN2CYP2D6CYP2C19
SCHEMBL59840 0.77 GABBR2 (0.59) DPP4KMT2ASMN1; SMN2CYP2D6CYP2C19
Malic Acid SCHEMBL28405670 0.76 PTPRA (0.51) FFAR1DHODHKMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645939-B1 Very late antigen-4 (VLA) integrin antagonists; antiallergens, antiasthmatics, and antiinflammatory agents; multiple sclerosis, autoimmune disease treatment MERCK & CO., INC. 2003-11-11 US disclosed
EP-1034164-A4 SUBSTITUTED BETA-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS MERCK & CO INC (US) 2001-07-11 EP disclosed
EP-1034164-A1 SUBSTITUTED BETA-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS Merck & Co., Inc. (US) 2000-09-13 EP disclosed
WO-1999026921-A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 1999-06-03 WO disclosed